CONFLUENT INC-CLASS A (CFLT)

US20717M1036 - Common Stock

28.53  +1.18 (+4.31%)

After market: 28.53 0 (0%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CFLT. CFLT was compared to 276 industry peers in the Software industry. The financial health of CFLT is average, but there are quite some concerns on its profitability. CFLT is valued quite expensively, but it does show have an excellent growth rating.



1

1. Profitability

1.1 Basic Checks

CFLT had positive earnings in the past year.
In the past year CFLT has reported a negative cash flow from operations.
CFLT had negative earnings in each of the past 5 years.
CFLT had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -17.99%, CFLT is doing worse than 65.33% of the companies in the same industry.
The Return On Equity of CFLT (-54.64%) is worse than 66.42% of its industry peers.
Industry RankSector Rank
ROA -17.99%
ROE -54.64%
ROIC N/A
ROA(3y)-17.31%
ROA(5y)-28.33%
ROE(3y)-51.25%
ROE(5y)-73.21%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CFLT has a Gross Margin (70.44%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CFLT has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CFLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.44%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.14%
GM growth 5Y-1.21%

4

2. Health

2.1 Basic Checks

CFLT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CFLT has been increased compared to 1 year ago.
Compared to 1 year ago, CFLT has an improved debt to assets ratio.

2.2 Solvency

An Altman-Z score of 2.75 indicates that CFLT is not a great score, but indicates only limited risk for bankruptcy at the moment.
CFLT has a Altman-Z score (2.75) which is comparable to the rest of the industry.
CFLT has a Debt/Equity ratio of 1.34. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CFLT (1.34) is worse than 76.28% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.34
Debt/FCF N/A
Altman-Z 2.75
ROIC/WACCN/A
WACC9.75%

2.3 Liquidity

CFLT has a Current Ratio of 4.62. This indicates that CFLT is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CFLT (4.62) is better than 86.86% of its industry peers.
A Quick Ratio of 4.62 indicates that CFLT has no problem at all paying its short term obligations.
CFLT has a Quick ratio of 4.62. This is amongst the best in the industry. CFLT outperforms 86.86% of its industry peers.
Industry RankSector Rank
Current Ratio 4.62
Quick Ratio 4.62

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 103.51% over the past year.
Looking at the last year, CFLT shows a very strong growth in Revenue. The Revenue has grown by 32.61%.
CFLT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 64.15% yearly.
EPS 1Y (TTM)103.51%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q200%
Revenue 1Y (TTM)32.61%
Revenue growth 3Y48.64%
Revenue growth 5Y64.15%
Revenue growth Q2Q26.37%

3.2 Future

Based on estimates for the next years, CFLT will show a very strong growth in Earnings Per Share. The EPS will grow by 198.07% on average per year.
The Revenue is expected to grow by 23.86% on average over the next years. This is a very strong growth
EPS Next Y815.45%
EPS Next 2Y312.88%
EPS Next 3Y198.07%
EPS Next 5YN/A
Revenue Next Year24.07%
Revenue Next 2Y24.62%
Revenue Next 3Y25.17%
Revenue Next 5Y23.86%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 1426.50, CFLT can be considered very expensive at the moment.
CFLT's Price/Earnings ratio is in line with the industry average.
CFLT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 25.20.
The Price/Forward Earnings ratio is 155.83, which means the current valuation is very expensive for CFLT.
CFLT's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.60, CFLT is valued quite expensively.
Industry RankSector Rank
PE 1426.5
Fwd PE 155.83

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CFLT's earnings are expected to grow with 198.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.75
PEG (5Y)N/A
EPS Next 2Y312.88%
EPS Next 3Y198.07%

0

5. Dividend

5.1 Amount

CFLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CONFLUENT INC-CLASS A

NASDAQ:CFLT (4/23/2024, 7:00:00 PM)

After market: 28.53 0 (0%)

28.53

+1.18 (+4.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.92B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 1426.5
Fwd PE 155.83
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.75
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.99%
ROE -54.64%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 70.44%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 1.34
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.62
Quick Ratio 4.62
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)103.51%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y815.45%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)32.61%
Revenue growth 3Y48.64%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y